ALPA

Alpa Laboratories Share Price

₹111.64 +1.36 (1.23%)

05 Nov, 2024 17:14

SIP TrendupStart SIP in ALPA

Start SIP

Performance

  • Low
  • ₹108
  • High
  • ₹113
  • 52 Week Low
  • ₹70
  • 52 Week High
  • ₹145
  • Open Price₹109
  • Previous Close₹110
  • Volume20,492

Investment Returns

  • Over 1 Month -11.14%
  • Over 3 Month + 19.31%
  • Over 6 Month + 17.58%
  • Over 1 Year + 52.72%
SIP Lightning

Smart Investing Starts Here Start SIP with Alpa Laboratories for Steady Growth!

Alpa Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 12.4
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 235
  • P/B Ratio
  • 1.5
  • Average True Range
  • 5.53
  • EPS
  • 8.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.37
  • RSI
  • 43.65
  • MFI
  • 28.64

Alpa Laboratories Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations21.4423.6127.3132.3925.43
Total Income From Operations21.4423.6127.3132.3925.43
P/L Before Interest, Excpt. Items & Tax5.166.945.335.783.02
P/L Before Exceptional Items & Tax5.116.645.305.743.00
P/L After Tax from Ordinary Activities5.123.554.535.743.03
Net Profit/Loss For the Period5.123.554.535.743.03
IndicatorMar 24Mar 23
Revenue From Operations [Gross]107.9292.41
Revenue From Operations [Net]107.9292.41
Total Operating Revenues108.7492.96
Total Revenue123.61102.36
Total Expenses102.9486.43
Profit/Loss Before Tax20.6715.93
Profit/Loss For The Period16.7812.62
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity3.708.82
Net Cash Used In Investing Activity-12.452.14
Net Cash Used in Finance Activity2.26-3.48
Net Inc/Dec In Cash And Equivalent-6.497.48
Cash And Equivalent End Of Year3.6610.13
IndicatorMar 24Mar 23
Total Share Capital21.0421.04
Total Non-Current Liabilities2.403.06
Total Current Liabilities28.0629.92
Total Capital And Liabilities192.42177.50
Total Non-Current Assets32.6529.29
Total Current Assets159.77148.21
Total Assets192.42177.50
Indicator20242023
EBIT Margin (%)19.3717.37
Return On Capital Employed (%)12.8110.94
Return On Equity (%)10.358.73
Long Term Debt To Equity (%)0.000.53
Book Value/Share (INR)76.9868.69
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations21.4423.6127.3132.3925.43
Total Income From Operations21.4423.6127.3132.3925.43
P/L Before Interest, Excpt. Items & Tax5.156.955.305.813.02
P/L Before Exceptional Items & Tax5.106.655.285.793.00
P/L After Tax from Ordinary Activities5.103.554.515.793.03
Net Profit/Loss For the Period5.103.554.515.793.03
IndicatorMar 24Mar 23
Revenue From Operations [Gross]107.9292.41
Revenue From Operations [Net]107.9292.41
Total Operating Revenues108.7492.96
Total Revenue123.63102.32
Total Expenses102.9586.43
Profit/Loss Before Tax20.6815.89
Profit/Loss For The Period16.7812.58
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity3.658.90
Net Cash Used In Investing Activity-13.342.13
Net Cash Used in Finance Activity2.58-3.79
Net Inc/Dec In Cash And Equivalent-7.107.24
Cash And Equivalent End Of Year3.118.81
IndicatorMar 24Mar 23
Total Share Capital21.0421.04
Total Non-Current Liabilities2.400.78
Total Current Liabilities28.0731.92
Total Capital And Liabilities182.37167.27
Total Non-Current Assets21.3918.14
Total Current Assets160.98149.13
Total Assets182.37167.27
Indicator20242023
EBIT Margin (%)19.3517.33
Return On Capital Employed (%)13.6311.90
Return On Equity (%)11.049.34
Long Term Debt To Equity (%)0.000.57
Book Value/Share (INR)72.2063.96

Alpa Laboratories Technicals

EMA & SMA

Current Price
₹111.64
+ 1.36 (1.23%)
pointer
  • stock-down_img
  • Bullish Moving Average 7
  • stock-up_img
  • Bearish Moving Average 9
  • 20 Day
  • ₹113.93
  • 50 Day
  • ₹112.85
  • 100 Day
  • ₹107.40
  • 200 Day
  • ₹100.28

Resistance and Support

111.36 Pivot Speed
  • R3 118.02
  • R2 116.16
  • R1 113.22
  • S1 108.42
  • S2 106.56
  • S3 103.62

Is Alpa Laboratories Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Alpa Laboratories has an operating revenue of Rs. 104.75 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 19% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 13% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 87 which is a GOOD score indicating consistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Alpa Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-13 Quarterly Results & A.G.M.
2024-05-28 Audited Results
2024-02-13 Quarterly Results
2023-11-07 Quarterly Results
2023-08-14 Quarterly Results

Alpa Laboratories F&O

Alpa Laboratories Shareholding Pattern

57.29%
0.74%
36.09%
5.88%
  • NSE Symbol
  • ALPA
  • BSE Symbol
  • 532878
  • Managing Director
  • Mr. Paresh Chawla
  • ISIN
  • INE385I01010

Alpa Laboratories FAQs

Alpa Laboratories share price is ₹111 As on 05 November, 2024 | 17:00

The Market Cap of Alpa Laboratories is ₹234.9 Cr As on 05 November, 2024 | 17:00

The P/E ratio of Alpa Laboratories is 12.4 As on 05 November, 2024 | 17:00

The PB ratio of Alpa Laboratories is 1.5 As on 05 November, 2024 | 17:00

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form